{
    "clinical_study": {
        "@rank": "159762", 
        "arm_group": [
            {
                "arm_group_label": "Lyxumia", 
                "arm_group_type": "Other", 
                "description": "4 weeks Luxumia plus another 4 weeks combination"
            }, 
            {
                "arm_group_label": "Lantus", 
                "arm_group_type": "Other", 
                "description": "4 weeks Lantus plus another 4 weeks combination"
            }
        ], 
        "brief_summary": {
            "textblock": "Impact of combined Lantus (insulin glargine) and Lyxumia(lixisenatide) on insulin secretion\n      and gastric emptying"
        }, 
        "brief_title": "Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "Impact of combined Lantus (insulin glargine) and Lyxumia(lixisenatide) on insulin secretion\n      and gastric emptying"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with type 2 diabetes mellitus diagnosed at least one year before the\n             screening visit not previously treated with glitazones, insulin or GLP-1 agonists\n\n          -  Inadequately controlled diabetes mellitus\n\n        Exclusion Criteria:\n\n          -  Subjects with type 1 diabetes, maturity onset diabetes of the young (MODY) or\n             secondary forms of diabetes such as due to pancreatitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01910194", 
            "org_study_id": "LanLyx"
        }, 
        "intervention": {
            "arm_group_label": [
                "Lyxumia", 
                "Lantus"
            ], 
            "intervention_name": "Luyxumia  versus Lantus", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Glargine", 
                "Insulin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "contact": {
                    "email": "juris.meier@rub.de", 
                    "last_name": "Juris J Meier, MD", 
                    "phone": "+49234509", 
                    "phone_ext": "2711"
                }, 
                "facility": {
                    "address": {
                        "city": "Bochum", 
                        "country": "Germany", 
                        "zip": "44791"
                    }, 
                    "name": "St. Josef-Hospital, University Hospital, Ruhr"
                }, 
                "investigator": {
                    "last_name": "Juris J Meier, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "regulatory@profil.com", 
                    "last_name": "Christoph Kapitza, MD", 
                    "phone": "+4921314018", 
                    "phone_ext": "145"
                }, 
                "facility": {
                    "address": {
                        "city": "Neuss", 
                        "country": "Germany", 
                        "zip": "41460"
                    }, 
                    "name": "Profil Institut f\u00fcr Stoffwechselforschung GmbH"
                }, 
                "investigator": {
                    "last_name": "Christoph Kapitza, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Bicentric Open-label, Randomized, Two-parallel-group Study Investigating the Impact of Combined Lantus Insulin Glargine) and Lyxumia(Lixisenatide) on Insulin Secretion and Gastric Emptying in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled on Diet and Oral Antidiabetic Medication", 
        "overall_contact": {
            "email": "juris.meier@rub.de", 
            "last_name": "Juris J Meier, MD", 
            "phone": "+49234509", 
            "phone_ext": "2711"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "AUCISEC(0-10min)", 
            "safety_issue": "No", 
            "time_frame": "Within 0 to 10 min after iv glucose challenge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01910194"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
        "sponsors": {
            "collaborator": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}